Integrated Metabolomics and Gut Microbiome Analysis Reveal the Role of Demethylzeylasteral in Alleviating Ulcerative Colitis in Mice
Abstract
Demethylzeylasteral (DMLL) is a natural compound isolated from the root of the herbal plant Tripterygium wilfordii Hook. F. It exhibits various pharmacological activities, yet the therapeutic effects against ulcerative colitis (UC) remain poorly understood. In this study, multiomics analysis revealed that DMLL alleviated DSS-induced experimental colitis by reconstructing gut microbiota and improving metabolic dysbiosis. The Bacteroidota phylum and genera of norank_f_Muribaculaceae and Ruminococcus with beneficial potential for UC were the major gut flora influenced by DMLL treatment. In terms of microbiota-derived metabolites, DMLL primarily enriched tryptophan metabolites, secondary bile acids, and nicotinamide. These compounds possess anti-inflammatory activity and protective effects for intestinal epithelial barrier, subsequently altered metabolic pathways, and improved impaired host gut homeostasis. In addition, we found significantly elevated levels of indolelactic acid (ILA) in the cecum of colitis mice and showed a strong positive correlation with UC symptoms, whereas serum levels of ILA were remarkably reduced and exhibited a negative association with UC, suggesting its dual role in colitis. Importantly, DMLL treatment effectively restored ILA levels in both the cecum and the systemic circulation. These findings provide novel mechanistic insights into the anticolitis effect of DMLL in mice, highlighting the crucial role of gut microbiota in its therapeutic action.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.